This page shows the latest Vaccine news and features for those working in and with pharma, biotech and healthcare.
COVID-19 vaccines, subject to authorisation from the US Food and Drug Administration (FDA). ... Vaccines have been and will remain critical to protecting people of all ages against COVID-19.
RSV, Bavarian Nordic’s vaccine candidate, to address the unmet medical need in the proposed target population. ... The incorporation of five antigens sets MVA-BN RSV apart from other RSV vaccine candidates currently in development.
Preliminary laboratory studies show both vaccines neutralise Omicron BA.4 and BA.5. ... The data shows that a booster dose of both Omicron-adapted vaccines gave a considerably higher immune response against Omicron BA.1, compared to Pfizer/BioNTech’s
The VAT08 vaccine trial assessed an adjuvant bivalent D614 and Beta (B.1.351) vaccine. ... Speaking on behalf of GSK, Roger Connor, president of GSK vaccines, said: “The positive data shows efficacy of our protein-based, bivalent adjuvanted vaccine
economic sanctions and an obligation to deliver life-saving vaccines and medicines regardless of circumstances.
Moderna, a biotech company specialising in messenger RNA (mRNA) therapeutics and vaccines, and the UK government have reached an agreement in principle for an mRNA Innovation and Technology Center in the ... The company, with the support of the UK
More from news
Approximately 235 fully matching, plus 1,511 partially matching documents found.
While other sectors were plunged into chaos, COVID-19 highlighted our industry’s remarkable capacity for innovation, with new vaccines and treatments being developed, tested and approved in record time.
The speed with which systems changed to cope with COVID-19 and the solutions that emerged, over and above the vaccines, demonstrated how agile the industry is.
In our most recent work in COVID-19 vaccine and treatment trials, there were several key ways that intentional a priori design and execution helped broaden participation among underserved populations that ... key. In our work on US-based COVID-19 vaccine
During the pandemic, we have accelerated recruitment for COVID-19 trials to explore new treatment options for those that can’t be helped by the vaccines.
It has accelerated and improved understanding of the virus, the development and assessment of vaccines, treatments and public health strategies. ... Similarly, those willing to share their data with pharmaceutical companies jumps from 23% to 60% if used
More from intelligence
Approximately 6 fully matching, plus 138 partially matching documents found.
In this role, he oversaw all media relations for the UK’s COVID-19 vaccination programme, providing strategic advice to Vaccines Minister Nadhim Zahawi and Health and Social Care Secretary Matt
Hornby has led communications for the UK government’s Vaccine Taskforce and previously led media and communications for GlaxoSmithKline.
Over the course of his most recent stint at Merck, the company has achieved over 100 regulatory approvals for its medicines and vaccines globally. ... As a result of Roger’s hands-on and inspirational leadership, MRL is well positioned to bring forward
In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
More from appointments
Approximately 5 fully matching, plus 66 partially matching documents found.
25. 5. It's bridging the gender data gap. As we mentioned in our recent blog ‘Why the COVID-19 vaccines are a women’s health issue’, there is a concerning
BioNTech’s Project Lightspeed is a case study in this – setting the highest standard to accelerate the development and commercialization of a COVID-19 vaccine in record time.
This work is ongoing as the virus mutates; last month, it was announced that Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant. ... While Covid-19 vaccine trials have garnered headlines these have
This again can be particularly powerful for comparisons of risk – such as the risk of adverse side effects from Covid-19 vaccines.
I got a sort of full check-up and she made sure I had all my vaccines and sent me for my eyes checking and stuff.
More from PMHub
Approximately 16 fully matching, plus 99 partially matching documents found.
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...